Description: Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, opthalomology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances, as well as over-the-counter products. Sun Pharmaceutical Industries Limited was founded in 1983 and is based in Mumbai, India.
Home Page: www.sunpharma.com
Sun House
Mumbai,
400063
India
Phone:
91 22 4324 4324
Officers
| Name | Title |
|---|---|
| Mr. Dilip Shantilal Shanghvi | MD & Exec. Director |
| Mr. C. S. Muralidharan | Chief Financial Officer |
| Mr. Sailesh Trambaklal Desai | Whole Time Director |
| Mr. Kalyanasundaram Subramanian | CEO of India Bus. and Emerging Markets & Whole-Time Director |
| Mr. Sunil R. Ajmera | Company Sec. |
| Mr. Arun Sawhney | Pres |
| Mr. Govind Kishanlal Jaju | Pres and Global Head of Technical Operations, Supply Chain,Procurement & Api Marketing |
| Mr. Indrajit Banerjee | Pres |
| Mr. Davinder Singh | Sr. Vice-Pres of Sun Pharmaceutical Global Operations |
| Mr. Atanu Roy | Sr. VP & Chief Information Officer |
Exchange: BSE
Country: IN : India
Currency: Indian Rupee (INR)
| Forward PE: | 24.6305 |
|---|---|
| Trailing PE: | 342.1569 |
| Price-to-Book MRQ: | 4.4842 |
| Price-to-Sales TTM: | 5.8518 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 36000 |